Tuberde, Wennie, Jr. B.
HRN: 23-94-23 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2023
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
10/22/2023
10/29/2023
PO
8ml
BID
T/C UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes